ARTICAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Articaine, and when can generic versions of Articaine launch?
Articaine is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in ARTICAINE is articaine hydrochloride; epinephrine bitartrate. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the articaine hydrochloride; epinephrine bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ARTICAINE?
- What are the global sales for ARTICAINE?
- What is Average Wholesale Price for ARTICAINE?
Summary for ARTICAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| What excipients (inactive ingredients) are in ARTICAINE? | ARTICAINE excipients list |
| DailyMed Link: | ARTICAINE at DailyMed |
US Patents and Regulatory Information for ARTICAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | articaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 079138-001 | Jun 18, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
